title: Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
abstract: Androgens via their cognate receptor may be involved in the development and progression of prostate cancer. The aim of this study was to determine whether tea polyphenols have inhibitory effects on androgen action in an androgen-responsive, prostate cancer cell line, LNCaP. The tea polyphenol, EGCG, inhibited LNCaP cell growth and the expression of androgen regulated PSA and hK2 genes. Moreover, EGCG had a significant inhibitory effect on the androgenic inducibility of the PSA promoter. Immunoblotting detected a decrease in androgen receptor protein with treatments of the tea polyphenols EGCG, GCG and theaflavins. Northern blot analysis showed decreased levels of androgen receptor mRNA by EGCG. Transient transfections demonstrated that EGCG and theaflavins could repress the transcriptional activities of the androgen receptor promoter region. An Sp1 binding site in the androgen receptor gene promoter is an important regulatory component for its expression. This study suggests Sp1 is the target for the tea polyphenols because treatments of EGCG decreased the expression, DNA binding activity and transactivation activity of Sp1 protein. In conclusion, we have described a new property of tea polyphenols that inhibits androgen action by repressing the transcription of the androgen receptor gene.
authors.affiliation: Department of Urology, Mayo Graduate School, Mayo Foundation, Rochester, Minnesota, MN 55905, USA.
authors.forename: F
authors.initials: F
authors.lastname: Ren
authors.forename: S
authors.initials: S
authors.lastname: Zhang
authors.forename: S H
authors.initials: SH
authors.lastname: Mitchell
authors.forename: R
authors.initials: R
authors.lastname: Butler
authors.forename: C Y
authors.initials: CY
authors.lastname: Young
mesh_terms: D020121:5' Untranslated Regions / Q000187:drug effects; D002392:Catechin / Q000031:analogs & derivatives / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D015536:Down-Regulation; D005419:Flavonoids; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D010636:Phenols / Q000494:pharmacology*; D011108:Polymers / Q000494:pharmacology*; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000378:metabolism*; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism*; D012045:Regulatory Sequences, Nucleic Acid / Q000187:drug effects; D016329:Sp1 Transcription Factor / Q000187:drug effects; D013662:Tea / Q000737:chemistry*; D020840:Tissue Kallikreins / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D020121:5' Untranslated Regions; D005419:Flavonoids; D010636:Phenols; D011108:Polymers; D011944:Receptors, Androgen; D016329:Sp1 Transcription Factor; D013662:Tea; D002392:Catechin; C045651:epigallocatechin gallate; D020840:Tissue Kallikreins; D017430:Prostate-Specific Antigen